1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First in-human, phase I study of the safety, tolerability and pharmacokinetics (PK) of BPM31543 (topical calcitriol solution) in adult cancer patients: Preliminary results
    Meeting Abstract

    Goldfarb, S. B.; Stevens, J.; Brouwer, S.; Benaim, E.; Narain, N. R.; Sarangarajan, R.; Kracunas, A.; Jimenez, J. J.; Belum, V. R.; Ciccolini, K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Longitudinal smoking patterns in survivors of childhood cancer: A Childhood Cancer Survivor Study (CCSS) update
    Meeting Abstract

    Gibson, T. M.; Liu, W.; Armstrong, G. T.; Srivastava, D. K.; Hudson, M. M.; Leisenring, W. M.; Mertens, A.; Klesges, R.; Oeffinger, K. C.; Nathan, P. C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • First-line monotherapy with nivolumab (NIVO; anti-programmed death-1 [PD-1]) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy and correlation of outcomes with PD-1 ligand (PD-L1) expression
    Meeting Abstract

    Gettinger, S. N.; Hellmann, M. D.; Shepherd, F. A.; Antonia, S. J.; Brahmer, J. R.; Chow, L. Q. M.; Goldman, J. W.; Juergens, R. A.; Borghaei, H.; Ready, N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Cardiac and renal biomarker responses in a phase 1/2 study of NEOD001 in patients with AL amyloidosis and persistent organ dysfunction
    Meeting Abstract

    Gertz, M. A.; Landau, H. J.; Comenzo, R.; Seldin, D. C.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G.; Koller, M.; Liedtke, M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Patient-reported outcome instruments meaningful and relevant for tenosynovial giant cell tumor (TGCT): A qualitative study
    Meeting Abstract

    Gelhorn, H.; Tong, S.; Maclaine, G.; Healey, J. H.; Bukata, S. V.; Keedy, V. L.; Anthony, S. P.; Wagner, A. J.; Von Hoff, D. D.; Singh, A. S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II, open-label, multicenter study of the ALK inhibitor alectinib in an ALK+ non-small-cell lung cancer (NSCLC) US/Canadian population who had progressed on crizotinib (NP28761)
    Meeting Abstract

    Gandhi, L.; Shaw, A.; Gadgeel, S. M.; Riely, G.; Cetnar, J.; West, H. J.; Camidge, D. R.; Socinski, M. A.; Chiappori, A.; Mekhail, T.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Use of a novel radio-sensitizer for treatment of GBM
    Meeting Abstract

    Gainer, J. L.; Sheehan, J.; Larner, J. M.; Jones, D. R.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A comparison of toxicity profiles between standard and lower dose capecitabine (CAP) in breast cancer (BC): A meta-analysis
    Meeting Abstract

    Funakoshi, T.; Suzuki, M.; Muss, H. B.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A randomized, double-blind, placebo-controlled phase III study of cisplatin plus a fluoropyrimidine with or without ramucirumab as first-line therapy in patients with metastatic gastric or gastroesophogeal junction (GEJ) adenocarcinoma (RAINFALL, NCT02314117)
    Meeting Abstract

    Fuchs, C. S.; Tabernero, J.; Al-Batran, S. E.; Chau, I.; Ilson, D. H.; Van Cutsem, E.; Ferry, D.; Emig, M.; Melemed, A. S.; Vanvoorden, V.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save